Erythromycin/sulfafurazole
| Combination of | |
|---|---|
| Erythromycin | Macrolide antibiotic |
| Sulfafurazole | Sulfonamide antibiotic |
| Clinical data | |
| Trade names | Pediazole |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
Erythromycin/sulfafurazole (trade name Pediazole) is a combination drug with the antibiotics erythromycin and sulfafurazole (the latter is also known as sulfisoxazole).[citation needed]
It is indicated in acute otitis media in children, particularly when Hemophilus influenzae is the suspected pathogen.[1]
References
[edit]- ^ erythromycin base/sulfisoxazole at Medscape. Retrieved April 29, 2013. Patient handout: [1].
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |